Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin-Reference-Cited by-同舟云学术

Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin

Published:2017-03-14 Issue:3 Volume:22 Page:462
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Jandial Danielle,Krill Lauren,Chen Lixia,Wu Chunli,Ke Yu,Xie Jun,Hoang Bang,Zi Xiaolin

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/22/3/462/pdf

Reference48 articles.

1. Chemotherapy-related complication burden in patients with metastatic breast cancer in a real-world setting.

2. Systematic Review of the Side Effects Associated With Anti-HER2-Targeted Therapies Used in the Treatment of Breast Cancer, on Behalf of the EORTC Quality of Life Group

3. Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research

4. Expression of erbB Receptors and their Ligands in Breast Cancer: Implications to Biological Behavior and Therapeutic Response

5. Estrogen Receptors as Therapeutic Targets in Breast Cancer

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivin (BIRC5): Implications in cancer therapy;Life Sciences;2024-08

2. SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies;Frontiers in Oncology;2024-03-15

3. A Novel Tri-Hydroxy-Methylated Chalcone Isolated from Chromolaena tacotana with Anti-Cancer Potential Targeting Pro-Survival Proteins;International Journal of Molecular Sciences;2023-10-14

4. Anticancer Potential of Natural Chalcones: In Vitro and In Vivo Evidence;International Journal of Molecular Sciences;2023-06-19

5. Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review;Frontiers in Pharmacology;2023-04-05